Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06236022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus

Name: The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus — clinical trial record (NCT06236022)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SDCMK

StatusRecruiting

PhasePhase 4

SponsorTongji Hospital

Started2024-01-01

View on ClinicalTrials.gov ↗

Tongji Hospital

197 trials monitored

See 2 trials at risk

Sarcoma

947 trials monitored

See 53 trials at risk

Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.

Trial Details

NCT Number	NCT06236022
Lead Sponsor	Tongji Hospital Collaborators: Wuhan Central Hospital, Wuhan Fourth Hospital, Wuhan University
Conditions	Dilated Cardiomyopathy, Kaposi's Sarcoma-Associated Herpesvirus Infection
Enrollment	276 participants
Start Date	2024-01-01
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-02-01